Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Radiation Injury - Pipeline Review, H2 2017 - Research and Markets

Research and Markets
Posted on: 20 Dec 17

The "Radiation Injury - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Radiation Injury - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Radiation Injury (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Radiation Injury (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiation Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Phase III, Preclinical, Discovery and Unknown stages are 1, 9, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Radiation Injury (Toxicology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Radiation Injury - Overview
  2. Radiation Injury - Therapeutics Development
  3. Pipeline Overview
  4. Pipeline by Companies
  5. Pipeline by Universities/Institutes
  6. Products under Development by Companies
  7. Products under Development by Universities/Institutes
  8. Radiation Injury - Therapeutics Assessment
  9. Assessment by Target
  10. Assessment by Mechanism of Action
  11. Assessment by Route of Administration
  12. Assessment by Molecule Type
  13. Radiation Injury - Companies Involved in Therapeutics Development
  • FirstString Research Inc
  • PharmaIN Corp
  • Synedgen Inc
  • Tonix Pharmaceuticals Holding Corp
  • Windtree Therapeutics Inc

For more information about this report visit

View source version on

Business Wire

Last updated on: 20/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.